• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSS0700068 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products(7) New Drug Application 2007-12-07 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2011-04-14 view
X0306108 注射用重组人甲状旁腺激素(1-34) parathyroid hormone Lyophilized Biological Products(7) New Drug Application 2003-12-10 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2004-09-10 view
CYSB1900326 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products Supplementary Application 2019-09-19 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2019-12-13 view
CXSL0500003 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products(7) New Drug Application 2005-02-22 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2005-11-23 view
CXSB1400017 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products Supplementary Application 2014-12-26 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2016-10-11 view
X0304086 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products(7) New Drug Application 2004-03-17 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2004-06-23 view
CYSB1300123 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products Supplementary Application 2013-06-03 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2014-01-03 view
X0400429 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 Lyophilized Biological Products(7) New Drug Application 2004-02-04 上海赛金生物医药有限公司 Shanghai Celgen Bio-Pharmaceutical Co Ltd Certificate Issued 2004-08-30 view